Novome Biotechnologies Inc.

Plus: Cargo hires Laport as CMO and updates from SVB and Genascence

After creating microbes that can degrade molecules in the gut, the Tencent-backed company is moving on microbes that can produce biologics in vivo

Plus note deals for Alnylam, Sarepta and updates from Rubius, Relay, Forge, Owkin, Ori and more

Plus Berkeley Lights shares sharply lower on CEO transition, Street misses and updates from Anavex, Notable Labs and more

Gut levels of Novome’s engineered microbes depend on dosing of seaweed-derived prebiotic

Plus: Genentech to co-develop with Novome, Ligand to split, Secarna, Achilles and more

Plus: Arcturus, BioDelivery, Landmark Bio, Vitrolife, Novome and more

Piet Wigerinck will step down this year after serving as CSO for nine years at Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG), overseeing the Belgian biotech’s programs from the discovery of

Microbiome company emerges with $50M, lead program to treat hyperoxaluria with designed consortia

AMR Action Fund pushing antibiotic development but pull mechanisms needed urgently